A detailed history of Somerset Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Somerset Trust CO holds 2,697 shares of ABBV stock, worth $459,433. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,697
Previous 2,678 0.71%
Holding current value
$459,433
Previous $459,000 15.9%
% of portfolio
0.2%
Previous 0.19%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $3,112 - $3,787
19 Added 0.71%
2,697 $532,000
Q2 2024

Jul 09, 2024

BUY
$154.79 - $180.76 $113,770 - $132,858
735 Added 37.83%
2,678 $459,000
Q1 2024

Apr 05, 2024

BUY
$159.82 - $182.1 $24,452 - $27,861
153 Added 8.55%
1,943 $353,000
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $48,022 - $54,084
-349 Reduced 16.32%
1,790 $277,000
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $24,847 - $28,764
186 Added 9.52%
2,139 $318,000
Q2 2023

Jul 07, 2023

SELL
$132.51 - $164.9 $1,590 - $1,978
-12 Reduced 0.61%
1,953 $263,000
Q1 2023

Apr 05, 2023

SELL
$144.61 - $166.54 $41,358 - $47,630
-286 Reduced 12.71%
1,965 $313,000
Q4 2022

Jan 03, 2023

BUY
$138.31 - $165.87 $8,298 - $9,952
60 Added 2.74%
2,251 $364,000
Q3 2022

Oct 03, 2022

BUY
$134.21 - $153.93 $2,684 - $3,078
20 Added 0.92%
2,191 $294,000
Q2 2022

Jul 06, 2022

BUY
$137.62 - $174.96 $18,303 - $23,269
133 Added 6.53%
2,171 $333,000
Q1 2022

Apr 05, 2022

BUY
$131.98 - $163.75 $4,883 - $6,058
37 Added 1.85%
2,038 $330,000
Q4 2021

Jan 07, 2022

BUY
$107.43 - $135.93 $214,967 - $271,995
2,001 New
2,001 $271,000
Q2 2019

Jul 31, 2019

SELL
$65.7 - $83.98 $19,644 - $25,110
-299 Closed
0 $0
Q1 2019

Apr 09, 2019

BUY
$77.14 - $90.79 $23,064 - $27,146
299 New
299 $24,000
Q3 2018

Oct 15, 2018

SELL
$88.91 - $98.84 $38,409 - $42,698
-432 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$69.85 - $89.22 $30,175 - $38,543
432
432 $38,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Somerset Trust CO Portfolio

Follow Somerset Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Trust CO with notifications on news.